Search Results 1341-1350 of 17468 for Absence

1. Epilepsy - Doctors and departments - Mayo Clinic

   Anyone experience side effects while decreasing Keppra? 69 Replies Mon, Jan 12, 2026. sophiasmith01 · Adults with absence seizures. 50 Replies Mon, Dec 29, 2025.

2. Study to Evaluate the Safety, Tolerability and Antitumor Activity of Anti-B7-H3 Car-T Cell Injection (TX103) in Subjects With Recurrent or Progressive Grade 4 Glioma - Mayo Clinic

   ... absence of evidence of hemolysis or liver pathology) Except for elevated erythrocytes; alanine aminotransferases (ALT) and aspartate aminotransferase (AST) ...

3. Publications - Michael P. Oien, M.D. - Mayo Clinic

   Absent Stapedial Tendon: Imaging Features of an Underrecognized Entity : Clinical Neuroradiology. Clin Neuroradiol. 2023 Sep; 33 (3):645-651 Epub 2023 Jan ...

4. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   ... absence of an external trigger are permitted to enroll. Conditions requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone ...

5. Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations - Mayo Clinic

   ... absence of other known resistance mutations (eg, T790M, MET): * Non-classical driver EGFR mutations (eg, L861R, S768I, G719X). * EGFR acquired resistance ...

6. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

   If ALP is > 3 x ULN (in the absence of liver metastases) or > 5 x ULN (in the presence of liver metastases) and also has bone metastases, the liver-specific ...

7. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

   * Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any actionable driver oncogenes for which ...

8. Investigational Trial To Evaluate XC001 Delivered Via An Cardiac Catheter In Subjects With Chronic Angina. - Mayo Clinic

   Subjects may be rescreened after 6 weeks of adequate treatment and absence of ventricular thrombus by echocardiography. 4. Body mass index \> 45 kg/m2. 5 ...

9. Visiting Medical Student Clerkships - Obstetrics and Gynecology, Maternal-Fetal Medicine Subinternship (Minnesota)

   Not schedule any absences during the subinternship. Method of evaluation. Evaluation is based on the student's level of participation and display of ...

10. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

    ... absence of a non-ischemic cause - Pathological findings of a healed or healing myocardial 7. Subjects with chronic kidney disease, as defined by estimated ...